Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-5996
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease ; volume:14 ; number:1 ; day:22 ; month:3 ; year:2022 ; pages:1-7 ; date:12.2022
Diabetology & metabolic syndrome ; 14, Heft 1 (22.3.2022), 1-7, 12.2022
- Creator
-
Han, A Lum
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13098-022-00811-2
- URN
-
urn:nbn:de:101:1-2022061320240445500494
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Han, A Lum
- SpringerLink (Online service)
Other Objects (12)
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Liver-specific Coxsackievirus and adenovirus receptor deletion develop metabolic dysfunction–associated fatty liver disease
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Biochemical assessment of metabolic associated fatty liver disease
Diabetes and Fatty Liver
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Liver-specific Coxsackievirus and adenovirus receptor deletion develop metabolic dysfunction–associated fatty liver disease
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Biochemical assessment of metabolic associated fatty liver disease
Diabetes and Fatty Liver
Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
Role of liver sinusoidal endothelial cell in metabolic dysfunction-associated fatty liver disease
Hormone-based pharmacotherapy for metabolic dysfunction-associated fatty liver disease
Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
Metabolic dysfunction associated fatty liver disease in healthy weight individuals
Liver-specific Coxsackievirus and adenovirus receptor deletion develop metabolic dysfunction–associated fatty liver disease
Excess Body Weight and Metabolic (Dysfunction)-Associated Fatty Liver Disease (MAFLD)
Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease development
Risk Scores for Metabolic Dysfunction-Associated Fatty Liver Disease in Pediatric Obesity
Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives
Biochemical assessment of metabolic associated fatty liver disease